Document is current
Any future updates will be listed below
-
Authors
Rizk, John G.
Wenziger, Cachet
Tran, Diana
Hashemi, Leila
Moradi, Hamid
Streja, Elani
Ahluwalia, Amrita https://orcid.org/0000-0002-2064-5725
-
Funding
Funding for this research was provided by:
us veterans administration clinical services research & development program (COVID-19-8900-18, COVID-19-8900-18, COVID-19-8900-18)
- License Information
-
More Information
Article History
Accepted: 28 October 2021
First Online: 16 December 2021
Declarations
:
: This study was supported by the COVID Rapid Response award COVID-19-8900-18 from the US Veterans Administration Clinical Services Research & Development Program (to ES, HM, and AA). The data reported here have been supplied by the US Veterans Administration. Opinions expressed in this presentation are those of the authors and do not represent the official opinion of the US Department of Veterans Affairs or the US Government. ES is supported by a career development award from the Office of Research and Development of the Department of Veterans Affairs (IK2- CX 001266-01). HM is supported by a career development award from the Office of Research and Development of the Department of Veterans Affairs (1IK- CX 001043-01A2).
: This study was approved by the VA Long Beach Healthcare System’s Institutional Review Boards (IRB) and deemed exempt from the written consent requirement since all analyses were conducted using preexisting, de-identified data. This investigation conforms to the principles outlined in the declaration of Helsinki.
: Restrictions apply to the availability of data generated or analyzed during this study. The United States Department of Veterans Affairs (VA) places legal restrictions on access to veteran’s health care data, which includes both identifying data and sensitive patient information. The corresponding author will on request detail the restrictions and any conditions under which access to some data may be provided.
: HM has received research funding from Novartis and Amgen. ES has received support from Astra Zeneca and Edwards Lifesciences.
: Study concept and design: AA, ES, HM. Acquisition of data: CW, AA, ES, HM. Analysis and interpretation of data: CW, AA, ES, HM, JGR, LH. Statistical analysis: CW, AA, ES, HM .Drafting of the manuscript: CW, AA, ES, HM, JGR, LH .Critical revision of the revised manuscript: CW, DT, AA, ES, HM, JGR, LH.
Free to read: This content has been made available to all.
